Neurovascular bioelectronics medicine company Synchron Inc. has received good news in the form of a breakthrough device designation for its Stentrode. The U.S. FDA granted the designation for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback